DrugPatentWatch Database Preview
MACRILEN Drug Profile
When do Macrilen patents expire, and when can generic versions of Macrilen launch?
Macrilen is a drug marketed by Strongbridge Ireland and is included in one NDA. There are two patents protecting this drug.
This drug has seventy-two patent family members in thirty-one countries.
The generic ingredient in MACRILEN is macimorelin acetate. One supplier is listed for this compound. Additional details are available on the macimorelin acetate profile page.
Summary for MACRILEN
| International Patents: | 72 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 7 |
| Patent Applications: | 19 |
| Drug Prices: | Drug price information for MACRILEN |
| DailyMed Link: | MACRILEN at DailyMed |
Generic Entry Opportunity Date for MACRILEN
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for MACRILEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Strongbridge Ireland | MACRILEN | macimorelin acetate | FOR SOLUTION;ORAL | 205598-001 | Dec 20, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for MACRILEN
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Norway | 20025893 | ➤ Sign Up |
| Spain | 2288724 | ➤ Sign Up |
| Hong Kong | 1056555 | ➤ Sign Up |
| Portugal | 1344773 | ➤ Sign Up |
| China | 1431998 | ➤ Sign Up |
| Denmark | 1524272 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 0196300 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
